Document:

Document

Exhibit 10.10

FORM OF ASSIGNMENT AND ASSUMPTION AGREEMENT
THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), dated as of                , 2022, is made by and between nCino OpCo, Inc., a Delaware corporation (formerly known as nCino, Inc.) (“Assignor”), nCino, Inc., a Delaware corporation (formerly known as Penny HoldCo, Inc.) (“Assignee”) and              (the “Beneficiary”). Assignor, Assignee and Beneficiary are referred to collectively in this Agreement as the “Parties”.
The Assignor and Assignee are parties to that certain Agreement and Plan of Merger, dated as of November 16, 2021 (the “Merger Agreement”), by and among Assignor, Assignee, SimpleNexus, LLC, a Utah limited liability company (“SimpleNexus”), Dollar Merger Sub, Inc., a Delaware corporation (“nCino Merger Sub”), Penny Merger Sub, LLC, a Utah limited liability company (the “SimpleNexus Merger Sub”), Penny Blocker 1 Merger Sub, Inc., a Delaware corporation (“Blocker 1 Merger Sub”), Penny Blocker 2 Merger Sub, Inc., a Delaware corporation (“Blocker 2 Merger Sub”), Penny Blocker 3 Merger Sub, Inc., a Delaware corporation (“Blocker 3 Merger Sub”), Penny Blocker 4 Merger Sub, Inc., a Delaware corporation (“Blocker 4 Merger Sub” and, together with Blocker 1 Merger Sub, Blocker 2 Merger Sub, and Blocker 3 Merger Sub, the “Blocker Merger Subs”), Insight (Delaware) SN Blocker Corporation, a Delaware corporation (“Blocker 1”), Insight (Cayman) SN Blocker Corporation, a Delaware corporation (“Blocker 2”), ScarletFire SN Blocker Corporation, a Delaware corporation (“Blocker 3”), TLEO, Inc., a Delaware corporation (“Blocker 4” and, together with Blocker 1, Blocker 2 and Blocker 3, the “Blockers”), and Insight Venture Partners, LLC, a Delaware limited liability company, solely in its capacity as the Member Representative (as defined in the Merger Agreement), pursuant to which, among other things, (i) nCino Merger Sub merged with and into Assignor, with Assignor surviving such merger as a wholly owned subsidiary of Assignee, (ii) each of the Blocker Merger Subs merged with and into the respective corresponding Blocker, with each of the respective Blockers surviving as a wholly owned subsidiary of Assignee, and (iii) SimpleNexus Merger Sub merged with and into SimpleNexus, with SimpleNexus surviving as a wholly owned subsidiary of Assignee.
Assignor desires to transfer and assign to Assignee, and Assignee desires to accept such assignment and to assume from Assignor, all of Assignor’s right, title and interest in and to the executive agreement identified in Schedule I (the “Assigned Contract”), all as provided herein.
Accordingly, in consideration of the assumption by Assignee of the Assumed Liabilities (as defined below), and of the premises and the mutual promises set forth in this Agreement, and in consideration of the representations, warranties, and covenants contained in this Agreement, the Parties agree as follows:
1.Assignment and Assumption by Assignee.
(a)Assignment. Assignee hereby assumes, acquires and receives from Assignor, and Assignor hereby transfers, assigns, conveys and delivers to Assignee, all right, title, and interest Assignor has in the Assigned Contract.  Assignor shall continue to be party to the Assigned Contract and shall remain liable for all commitments, liabilities and obligations of Assignor existing prior to the date hereof under and pursuant to the Assigned Contract. 
(b)Assumption of Liabilities. Assignee hereby assumes, and agrees to pay, perform, fulfill and discharge all commitments, liabilities and obligations of Assignor under and pursuant the Assigned Contract (the “Assumed Liabilities”).
2.Representations and Warranties of Assignor. Assignor represents and warrants to Assignee and Beneficiary as follows:

(a)Organization of Assignor. Assignor is a corporation duly organized and validly existing and in good standing under the laws of Delaware.
(b)Authorization. Assignor has full power and authority to execute and deliver this Agreement and to perform its obligations under this Agreement. This Agreement constitutes the valid and legally binding obligation of Assignor, enforceable in accordance with its terms and conditions, subject only to applicable bankruptcy, moratorium, and similar laws and general principles of equity. The execution, delivery and performance of this Agreement has been duly authorized by Assignor.
(c)No Conflicts. The execution, delivery and performance by Assignor of this Agreement and the consummation of the transactions contemplated hereby, do not and will not: (a) violate or conflict with the certificate of incorporation, by-laws or other organizational documents of Assignor or (b) violate or conflict with any judgment, order, decree, statute, law, ordinance, rule or regulation applicable to Assignor.
(d)Assigned Contract. The Assigned Contract is valid and binding on Assignor in accordance with its terms and is in full force and effect. 
3.Representations and Warranties of Assignee. Assignee represents and warrants to Assignor and Beneficiary as follows:
(a)Organization of Assignee. Assignee is a corporation duly organized and validly existing and in good standing under the laws of the state of Delaware.
(b)Authorization. Assignee has full power and authority to execute and deliver this Agreement and to perform its obligations under this Agreement. This Agreement constitutes the valid and legally binding obligation of Assignee, enforceable in accordance with its terms and conditions, subject only to applicable bankruptcy, moratorium, and similar laws and general principles of equity. The execution, delivery and performance of this Agreement has been duly authorized by Assignee.
(c)No Conflicts The execution, delivery and performance by Assignee of this Agreement and the consummation of the transactions contemplated hereby, do not and will not: (a) violate or conflict with the certificate of incorporation, by-laws or other organizational documents of Assignee or (b) violate or conflict with any judgment, order, decree, statute, law, ordinance, rule or regulation applicable to Assignor.
4.Representations and Warranties of Beneficiary. Beneficiary represents and warrants to Assignor and Assignee as follows:
(a)Authorization. Beneficiary has full power and authority to execute and deliver this Agreement and to perform its obligations under this Agreement. This Agreement constitutes the valid and legally binding obligation of Beneficiary, enforceable in accordance with its terms and conditions, subject only to applicable bankruptcy, moratorium, and similar laws and general principles of equity. 
5.Consent to Assignment. The Beneficiary hereby approves the assignment of the Assigned Contract from Assignor to Assignee.
6.Further Assurances. If any further action is necessary, appropriate or otherwise reasonably requested to carry out the purposes and intent of this Agreement, each of the Parties 
2

shall take such further action (including the execution and delivery of such further instruments and documents) as any other Party reasonably may request. 
7.Miscellaneous.
(a)Governing Law. All issues and questions concerning the construction, validity, interpretation and enforceability of this Agreement and the exhibits and schedules hereto will be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.
(b)Jurisdiction. Any Party seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby will be brought and determined exclusively in the Delaware Court of Chancery of the State of Delaware; provided that if the Delaware Court of Chancery does not have subject matter jurisdiction, any such legal proceeding will be brought exclusively in the United States District Court for the District of Delaware or any other court of the State of Delaware, and each of the Parties hereby consents to the exclusive jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such legal proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such legal proceeding in any such court or that any such legal proceeding that is brought in any such court has been brought in an inconvenient forum. Process in any such legal proceeding may be served on any Party anywhere in the world, whether within or without the jurisdiction of any such court. 
(c)Entire Agreement. This Agreement constitutes the entire understanding between Assignor and Assignee with respect to the subject matter hereof and supersedes any other understanding or agreement of the Parties with respect to the matters set forth herein.
(d)Waivers, Amendments and Severability. This Agreement may not be amended except by written instrument, specifically referencing this Agreement, signed by each Party and any Beneficiary affected thereby. No failure or delay by any Party in exercising any right under this Agreement will operate as a waiver of, nor will any single or partial exercise preclude any other or further exercise of, any rights under this Agreement. No waiver of any provisions of this Agreement will be valid unless the same is in writing and signed by the Party so waiving. If any one of the provisions contained in this Agreement is found to be invalid, illegal, or unenforceable in any respect by a court of competent jurisdiction, the validity, legality, or enforceability of the remaining provisions contained in this Agreement will not in any way be affected or impaired by such a finding.
(e)Assignability; Binding Agreement. This Agreement may not be assigned by any Party without the prior written consent of each other Party affected thereby. This Agreement shall be binding upon and enforceable by, and shall inure to the benefit of, the Parties and their respective successors, heirs, executors, administrators and permitted assigns. Notwithstanding the foregoing, nothing in this Agreement is intended to give any person not named herein the benefit of any legal or equitable right, remedy or claim under this Agreement, except as expressly provided in this Agreement.
(f)Counterparts. This Agreement may be executed simultaneously in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute but one and the same document.
3

(Signature Page Follows)

4

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.

															
		ASSIGNEE:
	
		nCino, Inc. 
	
					
		By:		
		Name: 
		
		Title:
		
					
		ASSIGNOR:
	
		nCino OpCo, Inc.
	
					
		By:		
		Name: 
		
		Title:
		

Signature Page to Assignment and Assumption Agreement

									
		BENEFICIARY:
	
			
			
			
		[Name]
	

Signature Page to Assignment and Assumption Agreement

Schedule I
Assigned Contract
[              ]Exhibit 4.5

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE 

SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

As of December 31, 2021, Global
SPAC Partners Co. (“we,” “our,” “us” or the “Company”) had the following three classes
of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) its
units, consisting of one subunit and one-half of one redeemable warrant, with each whole warrant (as defined below) entitling the holder
thereof to purchase one share of Class A ordinary share (the “units”), (ii) its subunits, included as part of the units, each
consisting of one Class A ordinary share, $0.0001 par value per share, and one-quarter of one redeemable warrant (the “subunits”),
(iii) its public warrants, with each whole warrant exercisable for one Class A ordinary share for $11.50 per share (the “warrants”);
and (iii) its Class A ordinary shares.

 

Pursuant
to our memorandum and articles of association, our authorized capital stock consists of 220,000,000 ordinary shares, including 200,000,000
shares of Class A ordinary shares, $0.0001 par value and 20,000,000 Class B ordinary shares, $0.0001 par value, and 1,000,000
undesignated preference shares, $0.0001 par value. The following description summarizes the material terms of our capital stock and
does not purport to be complete. It is subject to, and qualified in its entirety by reference to, our amended and restated memorandum
and articles of association, which is incorporated by reference as an exhibit to our Annual Report on Form 10-K for the year ended
December 31, 2021 (the “Report”).

 

Defined terms used herein
but not otherwise defined shall have the meaning ascribed to such terms in the Report.

 

Units and Subunits

 

Unlike other blank check company
offerings, our units consist of one subunit and one-half of a warrant. Each subunit consists of one Class A ordinary share and one-quarter
of a warrant.

 

Each whole warrant entitles
the holder to purchase one Class A ordinary share. Pursuant to the warrant agreement, a warrant holder may exercise its warrants
only for a whole number of Class A ordinary shares. This means that only a whole warrant may be exercised at any given time by a
warrant holder. No fractional warrants will be issued upon separation of the units or subunits and only whole warrants will trade.

 

We will provide our holders
of public subunits with the opportunity to redeem all or a portion of their public subunits upon the completion of our initial business
combination at a per-subunit price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business
days prior to the consummation of our initial business combination, including interest (which interest shall be net of taxes payable)
divided by the number of then outstanding public subunits, subject to the limitations described herein. Our sponsor, affiliates, officers,
directors and I-Bankers have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights
with respect to their founder shares, placement shares, representative shares and public subunits in connection with the completion of
our initial business combination.

 

If we seek shareholder approval
of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to
the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with
any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as
defined under Section 13 of the Exchange Act), will be restricted from redeeming its public subunits with respect to more than an
aggregate of 15% of the subunits sold in our initial public offering, which we refer to as the “Excess Shares.” However, we
would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Our shareholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete
our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares
on the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we
complete the business combination. And, as a result, such shareholders will continue to hold that number of subunits exceeding 15% and,
in order to dispose of such subunits would be required to sell their subunits in open market transactions, potentially at a loss.

 

Ordinary Shares

 

Class A ordinary shareholders
and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders
and vote together as a single class, except as required by law; provided, that holders of our Class B ordinary shares have the right
to appoint all of our directors prior to our initial business combination and holders of our Class A ordinary shares are not entitled
to vote on the appointment of directors during such time. These provisions of our memorandum and articles of association may only be amended
by a special resolution passed by at least 90% of our ordinary shares voting in a general meeting. There is no cumulative voting with
respect to the appointment of directors, with the result that the holders of more than 50% of the founder shares voted for the appointment
of directors can appoint all of the directors. Our shareholders are entitled to receive ratable dividends when, as and if declared by
the Board of Directors out of funds legally available therefor.

 

      

    

    

 

In the event of a liquidation,
dissolution or winding up of the company after a business combination, our shareholders are entitled to share ratably in all assets remaining
available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference
over the ordinary shares. Our shareholders have no pre-emptive or other subscription rights. There are no sinking fund provisions applicable
to the ordinary shares, except that we will provide our shareholders with the opportunity to redeem their public subunits for cash equal
to their pro rata share of the aggregate amount then on deposit in the trust account, including interest (which interest shall be net
of taxes payable) upon the completion of our initial business combination, subject to the limitations described in the Report.

 

Redeemable Warrants

 

Each whole warrant entitles
the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below,
at any time commencing 30 days after the completion of our initial business combination. The warrants will expire five years after
the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

 

We will not be obligated to
deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise
unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then
effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration.
No warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to
exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of
the state of the exercising holder, or an exemption is available. In the event that the conditions in the two immediately preceding sentences
are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant
may have no value and expire worthless. In the event that a registration statement is not effective for the exercised warrants, the purchaser
of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying
such unit.

 

The warrants will become exercisable
30 days after the completion of our initial business combination. Because the warrants will be exercisable until their expiration date
of up to five years after the completion of our initial business combination, in order to comply with the requirements of Section 10(a)(3)
of the Securities Act following the consummation of our initial business combination under the terms of the warrant agreement, we have
agreed that, as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination,
we will use our best efforts to file, and within 60 business days following our initial business combination to have declared effective,
a post-effective amendment to the Registration Statement. We will use our best efforts to cause the same to become effective and to maintain
the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance
with the provisions of the warrant agreement. No warrants will be exercisable for cash unless we have an effective and current registration
statement covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to such Class A
ordinary shares. Notwithstanding the foregoing, if a registration statement covering the Class A ordinary shares issuable upon exercise
of the warrants is not effective within a specified period following the consummation of our initial business combination, warrant holders
may, until such time as there is an effective registration statement and during any period when we shall have failed to maintain an effective
registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities
Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to
exercise their warrants on a cashless basis.

 

Redemption of warrants for
cash when the price per Class A ordinary share equals or exceeds $18.00.    Once the warrants become exercisable,
we may call the warrants for redemption (except as described herein with respect to the placement warrants):

 

		●	in whole and not in part;

 

		●	at a price of $0.01 per warrant;

 

		●	upon not less than 30 days’ prior written notice
of redemption to each warrant holder; and

 

		●	if, and only if, the closing price of the Class A ordinary
shares equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which notice
of the redemption is sent to the warrant holders.

 

    2

    

    

 

If and when the warrants become
redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale
under all applicable state securities laws in the United States.

 

No fractional Class A
ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share,
we will round down to the nearest whole number of the number of Class A ordinary shares to be issued to the holder. If, at the time
of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement
(for instance, if we are not the surviving company in our initial business combination), the warrants may be exercised for such security.
At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the company (or surviving
company) will use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of
the warrants.

 

Redemption procedures and
cashless exercise.    If we call the warrants for redemption as described above, our management will have the
option to require any holder that wishes to exercise his, her or its warrant to do so on a “cashless basis” beginning on the
third trading day prior to the date on which notice of the redemption is sent to the holders of warrants. In determining whether to require
all holders to exercise their warrants on a “cashless basis,” our management will consider, among other factors, our cash
position, the number of warrants that are outstanding and the dilutive effect on our shareholders of issuing the maximum number of Class A
ordinary shares issuable upon the exercise of our warrants. If our management takes advantage of this option, all holders of warrants
would pay the exercise price by surrendering their warrants for that number of Class A ordinary shares equal to the quotient obtained
by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the
“fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair
market value” will mean the average closing price of the Class A ordinary shares for the 10 trading days ending on the third
trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If our management takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of Class A ordinary shares
to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise
in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. We believe
this feature is an attractive option to us if we do not need the cash from the exercise of the warrants after our initial business combination.
If we call our warrants for redemption and our management team does not take advantage of this option, our sponsor and its permitted transferees
would still be entitled to exercise their placement warrants for cash or on a cashless basis using the same formula described above that
other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis,
as described in more detail below.

 

A holder of a warrant may notify
us in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant,
to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s
actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A ordinary shares issued
and outstanding immediately after giving effect to such exercise.

 

    3

    

    

 

The warrants have certain
anti-dilution and adjustments rights upon certain events.

 

The warrants have been issued
in registered form under a warrant agreement between Continental, as warrant agent, and us. The warrant agreement provides that the terms
of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or correct any
mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant
agreement set forth in our prospectus, but requires the approval by the holders of at least 50% of the then outstanding public warrants
to make any change that adversely affects the interests of the registered holders. You should review a copy of the warrant agreement,
which has been filed as an exhibit to the Registration Statement, for a complete description of the terms and conditions applicable to
the warrants.

 

In addition, if (x) we
issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing
of our initial business combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue
price or effective issue price to be determined in good faith by us and in the case of any such issuance to our sponsor or their affiliates,
without taking into account any founder shares held by our initial holders or such affiliates, as applicable, prior to such issuance)
(the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 50% of the total
equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the completion of
our initial business combination (net of redemptions), and (z) the volume-weighted average trading price of our subunits or Class A
ordinary shares, as the case may be, during the 20 trading day period starting on the trading day prior to the day on which we complete
our initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price described adjacent to “Redemption of warrants for cash when the price per Class A ordinary
share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value
and the Newly Issued Price.

 

The warrants may be exercised
upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form
on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price
(or on a cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised.
The warrant holders do not have the rights or privileges of holders of Class A ordinary shares and any voting rights until they exercise
their warrants and receive Class A ordinary shares. After the issuance of Class A ordinary shares upon exercise of the warrants,
each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

 

Warrants may be exercised only
for a whole number of Class A ordinary shares. No fractional shares will be issued upon exercise of the warrants. If, upon exercise
of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest
whole number the number of Class A ordinary shares to be issued to the warrant holder.

 

4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]